November 9, 2012 โ Svelte Medical Systems announced it received conditional approval from the U.S. Food and Drug ...
Stents Bare Metal
Bare metal stents are mesh-like tubes of thin wire without a coating or covering. Ideally, bare metal stents will be covered by a new layer of endothelial cells, sealing it into the vessel wall, within a few weeks after implant. However, a percentage of patients have their body negatively respond to the implanted foreign body, resulting in the formation of neointimal hyperplasia, a growth of scar tissue over the stent. This can cause restenosis of the vessel segment, which led to the development of drug-eluting stents (DES) now used in most patients. However, DES require the patient to take long-term antiplatelet medication, so patients who are likely to be noncompliant are often given bare metal stents.ย ย
November 09, 2012
November 1, 2012 โ InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be ...
November 01, 2012
October 3, 2012 โ Stentys, a medical technology company commercializing the world's first and only self-apposing stent t ...
October 03, 2012
May 4, 2012 - The U.S. Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for the ...
May 04, 2012
April 2, 2012 โ Boston Scientific announced its support of the HORIZONS II AMI clinical trial, which is designed to ...
April 02, 2012
Feature | Mark Paquin
April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the ...
March 16, 2012
February 6, 2012 โ A medical technology company commercializing the world's first and only self-apposing stent to treat ...
February 06, 2012November 15, 2011 โ A clinical trial that compared the use of drug-eluting balloons (DEB) and bare metal stents (BMS) to ...
November 15, 2011
November 4, 2011 โ Medtronic Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant ...
November 04, 2011November 1, 2011 โ Boston Scientific released the schedule of its major events and product-related clinical research for ...
November 01, 2011
October 25, 2011 โ Stentys S.A. announced the publication of the results of the APPOSITION I clinical study in the ...
October 25, 2011
October 7, 2011 โ Boston Scientific Corp. has started patient enrollment in the Omega clinical trial, designed to ...
October 07, 2011
Feature | Dave Fornell
There have been several key news items from the U.S. stent market over the past year. These include the introduction of ...
September 26, 2011
August 31, 2011 โ Results of a recent randomized controlled study show the drug-eluting stent Xience V performs well in ...
August 31, 2011
August 17, 2011 โ OrbusNeich announced its Genous stent showed no significant difference in target vessel failure (TVF) ...
August 17, 2011ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now